These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25583842)

  • 21. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis.
    Buyukturkoglu K; Dworkin JD; Leiva V; Provenzano FA; Guevara P; De Jager PL; Leavitt VM; Riley CS
    Mult Scler Relat Disord; 2022 Dec; 68():104247. PubMed ID: 36274283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.
    Pellicano C; Kane RL; Gallo A; Xiaobai L; Stern SK; Ikonomidou VN; Evangelou IE; Ohayon JM; Ehrmantraut M; Cantor FK; Bagnato F
    J Neuroimaging; 2013 Jul; 23(3):445-52. PubMed ID: 23227967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
    Vanotti S; Smerbeck A; Benedict RH; Caceres F
    Clin Neuropsychol; 2016 Oct; 30(7):1023-31. PubMed ID: 27668977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests.
    Hanly JG; Omisade A; Su L; Farewell V; Fisk JD
    Arthritis Rheum; 2010 May; 62(5):1478-86. PubMed ID: 20155829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
    Erlanger DM; Kaushik T; Caruso LS; Benedict RH; Foley FW; Wilken J; Cadavid D; Deluca J
    J Neurol Sci; 2014 May; 340(1-2):123-9. PubMed ID: 24656433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual-cognitive processing deficits in pediatric multiple sclerosis.
    Smerbeck AM; Parrish J; Serafin D; Yeh EA; Weinstock-Guttman B; Hoogs M; Krupp LB; Benedict RH
    Mult Scler; 2011 Apr; 17(4):449-56. PubMed ID: 21343232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis.
    Guilloton L; Camdessanche JP; Latombe D; Neuschwander P; Cantalloube S; Thomas-Anterion C; Mercier B; Roggerone S; Maucort-Boulch D; Roche S; Jacquin-Courtois S;
    Ann Phys Rehabil Med; 2020 Mar; 63(2):116-122. PubMed ID: 30703524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
    Lapshin H; Audet B; Feinstein A
    Eur J Neurol; 2014 Feb; 21(2):281-6. PubMed ID: 24200243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between physical fitness and cognitive function in multiple sclerosis: does disability status matter?
    Sandroff BM; Pilutti LA; Benedict RH; Motl RW
    Neurorehabil Neural Repair; 2015; 29(3):214-23. PubMed ID: 25009224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.
    Sandry J; Simonet DV; Brandstadter R; Krieger S; Katz Sand I; Graney RA; Buchanan AV; Lall S; Sumowski JF
    Mult Scler Relat Disord; 2021 Jun; 51():102950. PubMed ID: 33887609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis.
    Amezcua L; Smith JB; Gonzales EG; Haraszti S; Langer-Gould A
    Neurology; 2020 Apr; 94(14):e1548-e1556. PubMed ID: 32152131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-person and remote administrations of the symbol digit modalities test are interchangeable among persons with multiple sclerosis.
    Levy S; Dvorak EM; Graney R; Staker E; Sumowski JF
    Mult Scler Relat Disord; 2023 Mar; 71():104553. PubMed ID: 36764285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
    Strober L; Chiaravalloti N; Moore N; DeLuca J
    Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
    Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
    Lapshin H; Lanctôt KL; O'Connor P; Feinstein A
    Mult Scler; 2013 Dec; 19(14):1905-12. PubMed ID: 23652217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distraction adds to the cognitive burden in multiple sclerosis.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Feinstein A
    Mult Scler; 2017 Jan; 23(1):106-113. PubMed ID: 27012660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.